3SBIO INC. is a HKEx-listed (HKEX:1530, \"3SBio\") fully integrated, biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, we are a pre-eminent player in China’s biopharmaceutical industry.
Diversified product portfolio – over 50 pharmaceuticals covering primarily oncology, autoimmune diseases, nephrology and dermatology as well as other therapeutic areas.
Established global Operation Presence, we have GMP certified state-of-the-art facilities in Shanghai, Shenyang, Hangzhou, Shenzhen, Shanghai and Italy.
Our product groups：
Recombinant Human Erythropoietin Injection (EPIAO), ,Recombinant human thrombopoietin injection (TPIAO) with indications for chemotherapy-induced thrombocytopenia (CIT) and platelet deficiency and Immune Thrombocytopenia (ITP),Etanercept:Recombinant human tumor necrosis factor-α receptor II – IgG Fc fusion protein for injection (YISAIPU) indication: Rheumatoid arthritis Ankylosing spondylitis and Psoriasis